BIOMAT Database Logo BIOMAT Database Logo

[Use of isoflurane as treatment for super-refractory status epilepticus]. 2023

O Plans-Galván, and X Daniel, and S Rosich, and V Blázquez-Alcaide, and D Gil-Castillejos, and M Bodí
Hospital Universitari Joan XXIII, 43007 Tarragona, España.

Super-refractory status epilepticus (SRSE) is a neurological condition with an important morbidity and mortality rate, for which few therapeutic options are available. Inhalation sedation with isoflurane is currently a compassionate-use treatment in Spanish intensive care units. Little has been written about its usefulness in the treatment of refractory and super-refractory status epilepticus, but it appears to be a useful and safe therapeutic alternative for this condition. This article reviews three cases of SRSE treated with isoflurane. The capacity of isoflurane to control seizures was assessed by electroencephalographic monitoring. Other variables assessed were time to seizure control, survival, functional outcome and occurrence of complications secondary to isoflurane. In the three cases reviewed, isoflurane proved to be effective for seizure control in patients affected by SRSE. Seizure control was accomplished quickly and the minimum dose required to obtain a burst-suppression pattern was titrated easily and rapidly. Despite controlling epilepsy, high mortality was observed (66.66%). This is explained by both the mortality of SRSE and the underlying pathologies of the patients who died. The use of isoflurane did not give rise to any complications. With the results obtained, it is feasible to think that the use of isoflurane is not related to lesions in the central nervous system reported in other articles, and this treatment can be considered effective and safe for the control of SRSE.

UI MeSH Term Description Entries
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D007530 Isoflurane A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012640 Seizures Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or "seizure disorder." Absence Seizure,Absence Seizures,Atonic Absence Seizure,Atonic Seizure,Clonic Seizure,Complex Partial Seizure,Convulsion,Convulsions,Convulsive Seizure,Convulsive Seizures,Epileptic Seizure,Epileptic Seizures,Generalized Absence Seizure,Generalized Tonic-Clonic Seizures,Jacksonian Seizure,Myoclonic Seizure,Non-Epileptic Seizure,Nonepileptic Seizure,Partial Seizure,Seizure,Seizures, Convulsive,Seizures, Focal,Seizures, Generalized,Seizures, Motor,Seizures, Sensory,Tonic Clonic Seizure,Tonic Seizure,Tonic-Clonic Seizure,Atonic Absence Seizures,Atonic Seizures,Clonic Seizures,Complex Partial Seizures,Convulsion, Non-Epileptic,Generalized Absence Seizures,Myoclonic Seizures,Non-Epileptic Seizures,Nonepileptic Seizures,Partial Seizures,Petit Mal Convulsion,Seizures, Auditory,Seizures, Clonic,Seizures, Epileptic,Seizures, Gustatory,Seizures, Olfactory,Seizures, Somatosensory,Seizures, Tonic,Seizures, Tonic-Clonic,Seizures, Vertiginous,Seizures, Vestibular,Seizures, Visual,Single Seizure,Tonic Seizures,Tonic-Clonic Seizures,Absence Seizure, Atonic,Absence Seizure, Generalized,Absence Seizures, Atonic,Absence Seizures, Generalized,Auditory Seizure,Auditory Seizures,Clonic Seizure, Tonic,Clonic Seizures, Tonic,Convulsion, Non Epileptic,Convulsion, Petit Mal,Convulsions, Non-Epileptic,Focal Seizure,Focal Seizures,Generalized Seizure,Generalized Seizures,Generalized Tonic Clonic Seizures,Generalized Tonic-Clonic Seizure,Gustatory Seizure,Gustatory Seizures,Motor Seizure,Motor Seizures,Non Epileptic Seizure,Non Epileptic Seizures,Non-Epileptic Convulsion,Non-Epileptic Convulsions,Olfactory Seizure,Olfactory Seizures,Partial Seizure, Complex,Partial Seizures, Complex,Seizure, Absence,Seizure, Atonic,Seizure, Atonic Absence,Seizure, Auditory,Seizure, Clonic,Seizure, Complex Partial,Seizure, Convulsive,Seizure, Epileptic,Seizure, Focal,Seizure, Generalized,Seizure, Generalized Absence,Seizure, Generalized Tonic-Clonic,Seizure, Gustatory,Seizure, Jacksonian,Seizure, Motor,Seizure, Myoclonic,Seizure, Non-Epileptic,Seizure, Nonepileptic,Seizure, Olfactory,Seizure, Partial,Seizure, Sensory,Seizure, Single,Seizure, Somatosensory,Seizure, Tonic,Seizure, Tonic Clonic,Seizure, Tonic-Clonic,Seizure, Vertiginous,Seizure, Vestibular,Seizure, Visual,Seizures, Generalized Tonic-Clonic,Seizures, Nonepileptic,Sensory Seizure,Sensory Seizures,Single Seizures,Somatosensory Seizure,Somatosensory Seizures,Tonic Clonic Seizures,Tonic-Clonic Seizure, Generalized,Tonic-Clonic Seizures, Generalized,Vertiginous Seizure,Vertiginous Seizures,Vestibular Seizure,Vestibular Seizures,Visual Seizure,Visual Seizures
D013226 Status Epilepticus A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30) Absence Status,Complex Partial Status Epilepticus,Generalized Convulsive Status Epilepticus,Non-Convulsive Status Epilepticus,Petit Mal Status,Simple Partial Status Epilepticus,Grand Mal Status Epilepticus,Status Epilepticus, Complex Partial,Status Epilepticus, Electrographic,Status Epilepticus, Generalized,Status Epilepticus, Generalized Convulsive,Status Epilepticus, Grand Mal,Status Epilepticus, Non-Convulsive,Status Epilepticus, Simple Partial,Status Epilepticus, Subclinical,Electrographic Status Epilepticus,Generalized Status Epilepticus,Non Convulsive Status Epilepticus,Status Epilepticus, Non Convulsive,Status, Absence,Status, Petit Mal,Subclinical Status Epilepticus
D057176 Compassionate Use Trials Providing an investigational therapy to a patient who is not eligible to receive that therapy in a clinical trial, but who has a serious or life-threatening illness for which other treatments are not available. Compassionate use trials allow patients to receive promising but not yet fully studied or approved therapies when no other treatment option exists. Also called expanded access trial. Compassionate Use,Expanded Access Trials,Humanitarian Device Exemption,Access Trial, Expanded,Compassionate Use Trial,Compassionate Uses,Device Exemption, Humanitarian,Device Exemptions, Humanitarian,Exemption, Humanitarian Device,Exemptions, Humanitarian Device,Expanded Access Trial,Humanitarian Device Exemptions,Trial, Compassionate Use,Trial, Expanded Access,Trials, Compassionate Use,Trials, Expanded Access,Use Trials, Compassionate,Use, Compassionate

Related Publications

O Plans-Galván, and X Daniel, and S Rosich, and V Blázquez-Alcaide, and D Gil-Castillejos, and M Bodí
Isoflurane treatment for refractory and super-refractory status epilepticus in dogs.
January 2024, Frontiers in veterinary science,
O Plans-Galván, and X Daniel, and S Rosich, and V Blázquez-Alcaide, and D Gil-Castillejos, and M Bodí
Commentary on Isoflurane in Refractory and Super-Refractory Status Epilepticus.
December 2021, Neurocritical care,
O Plans-Galván, and X Daniel, and S Rosich, and V Blázquez-Alcaide, and D Gil-Castillejos, and M Bodí
Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter Evaluation.
December 2021, Neurocritical care,
O Plans-Galván, and X Daniel, and S Rosich, and V Blázquez-Alcaide, and D Gil-Castillejos, and M Bodí
Management of super-refractory status epilepticus with isoflurane and hypothermia.
January 2014, Frontiers in neurology,
O Plans-Galván, and X Daniel, and S Rosich, and V Blázquez-Alcaide, and D Gil-Castillejos, and M Bodí
Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus.
December 2018, Continuum (Minneapolis, Minn.),
O Plans-Galván, and X Daniel, and S Rosich, and V Blázquez-Alcaide, and D Gil-Castillejos, and M Bodí
Treatment of Super-Refractory Status Epilepticus.
October 2015, Current neurology and neuroscience reports,
O Plans-Galván, and X Daniel, and S Rosich, and V Blázquez-Alcaide, and D Gil-Castillejos, and M Bodí
Treatment of Refractory and Super-refractory Status Epilepticus.
July 2018, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,
O Plans-Galván, and X Daniel, and S Rosich, and V Blázquez-Alcaide, and D Gil-Castillejos, and M Bodí
Management of Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus.
April 2022, Continuum (Minneapolis, Minn.),
O Plans-Galván, and X Daniel, and S Rosich, and V Blázquez-Alcaide, and D Gil-Castillejos, and M Bodí
Isoflurane Use in the Treatment of Super-Refractory Status Epilepticus is Associated with Hippocampal Changes on MRI.
June 2017, Neurocritical care,
O Plans-Galván, and X Daniel, and S Rosich, and V Blázquez-Alcaide, and D Gil-Castillejos, and M Bodí
Super-Refractory Status Epilepticus.
November 2015, Current neurology and neuroscience reports,
Copied contents to your clipboard!